Your browser doesn't support javascript.
loading
Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation.
Hagihara, Mao; Yamashita, Makoto; Ariyoshi, Tadashi; Eguchi, Shuhei; Minemura, Ayaka; Miura, Daiki; Higashi, Seiya; Oka, Kentaro; Nonogaki, Tsunemasa; Mori, Takeshi; Iwasaki, Kenta; Hirai, Jun; Shibata, Yuichi; Umemura, Takumi; Kato, Hideo; Asai, Nobuhiro; Yamagishi, Yuka; Ota, Akinobu; Takahashi, Motomichi; Mikamo, Hiroshige.
Afiliação
  • Hagihara M; Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute 480-1195, Japan; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Yamashita M; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Ariyoshi T; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Eguchi S; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Minemura A; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Miura D; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Higashi S; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Oka K; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Nonogaki T; Department of Pharmacy, College of Pharmacy Kinjo Gakuin University, Nagoya 463-8521, Japan.
  • Mori T; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Iwasaki K; Departments of Kidney Disease and Transplant Immunology, Aichi Medical University, Nagakute 480-1195, Japan.
  • Hirai J; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Shibata Y; Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute 480-1195, Japan.
  • Umemura T; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Kato H; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan; Department of Pharmacy, Mie University Hospital, Tsu, Mie, Japan.
  • Asai N; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Yamagishi Y; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan.
  • Ota A; Departments of Biochemistry, Aichi Medical University, Nagakute 480-1195, Japan.
  • Takahashi M; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan; R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama 331-0804, Japan.
  • Mikamo H; Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Japan. Electronic address: mikamo@aichi-med-u.ac.jp.
Cell Rep ; 41(11): 111755, 2022 12 13.
Article em En | MEDLINE | ID: mdl-36516771
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Infecções por Orthomyxoviridae / Clostridium butyricum Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Infecções por Orthomyxoviridae / Clostridium butyricum Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos